Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-21 4:15 pm Sale | 2025-08-21 | 13D | KEROS THERAPEUTICS INC KROS | ADAR1 Capital Management LLC | 5,389,264 13.270% | -1,700 (-0.03%) | Filing History |
| 2025-08-14 9:13 pm Purchase | 2025-06-30 | 13G | IBIO INC PAR $0.001 IBIO | ADAR1 Capital Management LLC | 1,794,055 9.900% | 698,088 (+63.70%) | Filing History |
| 2025-08-14 8:27 pm Purchase | 2025-06-30 | 13G | INHIBIKASE THERAPEUTICS INC CO IKT | ADAR1 Capital Management LLC | 7,737,694 9.900% | 743,448 (+10.63%) | Filing History |
| 2025-08-14 8:17 pm Purchase | 2025-06-30 | 13G | PROTHENA CORP PLC SHS PRTA | ADAR1 Capital Management LLC | 3,375,009 6.300% | 3,375,009 (New Position) | Filing History |
| 2025-08-14 8:07 pm Purchase | 2025-06-30 | 13G | BIOAGE LABS INC BIOA | ADAR1 Capital Management LLC | 1,937,123 5.400% | 1,937,123 (New Position) | Filing History |
| 2025-08-14 7:47 pm Purchase | 2025-06-30 | 13G | KIORA PHARMACEUTICALS INC KPRX | ADAR1 Capital Management LLC | 365,179 9.900% | 50,076 (+15.89%) | Filing History |
| 2025-08-14 7:39 pm Sale | 2025-06-30 | 13G | CELLECTAR BIOSCIENCES INC CLRB | ADAR1 Capital Management LLC | 2,962 0.100% | -119,862 (-97.59%) | Filing History |
| 2025-05-15 7:33 pm Purchase | 2025-03-31 | 13G | ACASTI PHARMA INC NO PAR ACST | ADAR1 Capital Management LLC | 1,502,143 9.990% | 472,146 (+45.84%) | Filing History |
| 2025-05-12 11:29 am Unchanged | 2025-05-12 | 13D | KEROS THERAPEUTICS INC KROS | ADAR1 Capital Management LLC | 5,390,964 13.270% | 0 (Unchanged) | Filing History |
| 2025-05-08 4:39 pm Unchanged | 2025-05-08 | 13D | KEROS THERAPEUTICS INC KROS | ADAR1 Capital Management LLC | 5,390,964 13.270% | 0 (Unchanged) | Filing History |
| 2025-04-28 6:43 pm Unchanged | 2025-04-24 | 13D | KEROS THERAPEUTICS INC KROS | ADAR1 Capital Management LLC | 5,390,964 13.290% | 0 (Unchanged) | Filing History |
| 2025-04-11 8:32 pm Purchase | 2025-04-04 | 13D | KEROS THERAPEUTICS INC KROS | ADAR1 Capital Management LLC | 5,390,964 13.290% | 5,390,964 (New Position) | Filing History |
| 2025-02-14 9:10 pm Purchase | 2024-12-31 | 13G | IBIO INC PAR $0.001 IBIO | ADAR1 Capital Management LLC | 1,095,967 9.990% | 129,669 (+13.42%) | Filing History |
| 2025-02-14 9:05 pm Sale | 2024-12-31 | 13G | ZURA BIO LTD ZURA | ADAR1 Capital Management LLC | 2,077,251 3.180% | -1,255,584 (-37.67%) | Filing History |
| 2025-02-14 9:04 pm Purchase | 2024-12-31 | 13G | INHIBIKASE THERAPEUTICS INC CO IKT | ADAR1 Capital Management LLC | 6,994,246 9.990% | 6,994,246 (New Position) | Filing History |
| 2025-02-14 9:04 pm Sale | 2024-12-31 | 13G | KALA BIO, INC. KALA | ADAR1 Capital Management LLC | 5,979 4.910% | -3,630 (-37.78%) | Filing History |
| 2024-11-14 4:49 pm Purchase | 2024-09-30 | 13G | KALA BIO, INC. KALA | ADAR1 Capital Management LLC | 9,609 9.990% | 9,609 (New Position) | Filing History |
| 2024-11-14 4:48 pm Purchase | 2024-09-30 | 13G | IBIO INC PAR $0.001 IBIO | ADAR1 Capital Management LLC | 966,298 9.990% | 966,298 (New Position) | Filing History |
| 2024-11-14 4:47 pm Purchase | 2024-09-30 | 13G | CELLECTAR BIOSCIENCES INC CLRB | ADAR1 Capital Management LLC | 122,824 8.510% | 122,824 (New Position) | Filing History |
| 2024-11-14 4:47 pm Purchase | 2024-09-30 | 13G | ZURA BIO LTD ZURA | ADAR1 Capital Management LLC | 3,332,835 5.100% | 3,332,835 (New Position) | Filing History |